PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO.JK)
IDR 545.0
(-2.68%)
IDR 545.0
(-2.68%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1323.93 Billion IDR | -13.89% |
| 2022 | 1516.06 Billion IDR | -11.97% |
| 2021 | 1708.03 Billion IDR | 33.89% |
| 2020 | 1296.94 Billion IDR | 11.16% |
| 2019 | 1160.98 Billion IDR | 23.99% |
| 2018 | 929.97 Billion IDR | 26.52% |
| 2017 | 743.01 Billion IDR | 17.68% |
| 2016 | 675.06 Billion IDR | 2.34% |
| 2015 | 576.27 Billion IDR | 3.64% |
| 2014 | 556.26 Billion IDR | -15.13% |
| 2013 | 599.14 Billion IDR | 27.78% |
| 2012 | 514.7 Billion IDR | 12.92% |
| 2011 | 456.22 Billion IDR | 31.81% |
| 2010 | 344.25 Billion IDR | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 219.63 Billion IDR | -20.09% |
| 2024 Q1 | 522.28 Billion IDR | 7.79% |
| 2024 Q2 | 277.64 Billion IDR | -42.31% |
| 2023 FY | - IDR | -13.89% |
| 2023 Q1 | 381.89 Billion IDR | -23.05% |
| 2023 Q2 | 200.06 Billion IDR | -47.61% |
| 2023 Q4 | 466.5 Billion IDR | 159.54% |
| 2023 Q3 | 179.74 Billion IDR | -10.16% |
| 2022 Q3 | 353.63 Billion IDR | 79.11% |
| 2022 Q1 | 378.98 Billion IDR | -25.19% |
| 2022 FY | - IDR | -11.97% |
| 2022 Q4 | 496.28 Billion IDR | 40.34% |
| 2022 Q2 | 197.43 Billion IDR | -47.9% |
| 2021 Q4 | 506.58 Billion IDR | 8.32% |
| 2021 Q1 | 345.39 Billion IDR | -9.34% |
| 2021 Q2 | 300.58 Billion IDR | -12.97% |
| 2021 Q3 | 467.66 Billion IDR | 55.59% |
| 2021 FY | - IDR | 33.89% |
| 2020 Q1 | 281.24 Billion IDR | -22.33% |
| 2020 Q3 | 322.18 Billion IDR | 42.74% |
| 2020 Q2 | 225.71 Billion IDR | -19.75% |
| 2020 FY | - IDR | 11.16% |
| 2020 Q4 | 380.96 Billion IDR | 18.25% |
| 2019 Q1 | 259.22 Billion IDR | 3.39% |
| 2019 Q4 | 362.09 Billion IDR | 41.65% |
| 2019 Q3 | 255.63 Billion IDR | 20.75% |
| 2019 Q2 | 211.7 Billion IDR | -18.33% |
| 2019 FY | - IDR | 23.99% |
| 2018 Q3 | 235.54 Billion IDR | 28.57% |
| 2018 FY | - IDR | 26.52% |
| 2018 Q4 | 250.72 Billion IDR | 6.45% |
| 2018 Q2 | 183.2 Billion IDR | -12.17% |
| 2018 Q1 | 208.58 Billion IDR | 21.95% |
| 2017 Q2 | 172.98 Billion IDR | 8.05% |
| 2017 Q4 | 171.04 Billion IDR | -10.07% |
| 2017 FY | - IDR | 17.68% |
| 2017 Q1 | 160.09 Billion IDR | 64.95% |
| 2017 Q3 | 190.18 Billion IDR | 9.94% |
| 2016 Q3 | 132.48 Billion IDR | -36.06% |
| 2016 Q4 | 97.05 Billion IDR | -26.74% |
| 2016 Q2 | 207.19 Billion IDR | 35.39% |
| 2016 FY | - IDR | 2.34% |
| 2016 Q1 | 153.03 Billion IDR | 6.58% |
| 2015 Q1 | 158.16 Billion IDR | 7.27% |
| 2015 Q3 | 106.7 Billion IDR | -36.42% |
| 2015 Q2 | 167.82 Billion IDR | 6.1% |
| 2015 FY | - IDR | 3.64% |
| 2015 Q4 | 143.58 Billion IDR | 34.57% |
| 2014 Q1 | 148.24 Billion IDR | -26.59% |
| 2014 Q3 | -14.04 Billion IDR | -105.12% |
| 2014 Q2 | 274.37 Billion IDR | 85.08% |
| 2014 Q4 | 147.44 Billion IDR | 1149.95% |
| 2014 FY | - IDR | -15.13% |
| 2013 Q4 | 201.95 Billion IDR | 0.51% |
| 2013 FY | - IDR | 27.78% |
| 2013 Q2 | 151.51 Billion IDR | 50.38% |
| 2013 Q3 | 200.93 Billion IDR | 32.61% |
| 2013 Q1 | 100.75 Billion IDR | 0.0% |
| 2012 FY | - IDR | 12.92% |
| 2011 FY | - IDR | 31.81% |
| 2010 FY | - IDR | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 255.91 Billion IDR | -417.335% |
| PT Merck Tbk | 239.49 Billion IDR | -452.809% |
| PT Phapros, Tbk | 120.77 Billion IDR | -996.208% |
| PT Pyridam Farma Tbk | 60.69 Billion IDR | -2081.21% |
| PT Tempo Scan Pacific Tbk | 1997.6 Billion IDR | 33.724% |